fda import alert glp-1 semaglutide tirzepatide green list The said it's aware of some Americans using unapproved versions of medications, which is said can be "risky for patients." HIMS Positioned Strongly Amid FDA

Statements Author contributions SW: Formal analysis, Writing original draft

Mediation analysis from the STEP trials found that of the additional 7.6-14.4% weight loss achieved with semaglutide versus placebo, less than 1 percentage point was mediated by gastrointestinal adverse events

As of 2026, it's becoming increasingly challenging to find explicit, universal deferral guidelines specifically mentioning every single newer medication, especially compounds like Tirzepatide that have only recently gained widespread clinical acceptance

Theyre ideal for people on low-carb or weight-loss plans, athletes, and those experiencing chronic fatigue

Es importante sealar que la tirzepatida no est indicada para el tratamiento de la diabetes tipo 1